MedTrace Logo

Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin

NCT02027532 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 430

Last updated 2018-07-11

No results posted yet for this study

Summary

The purpose of this study is to compare the incidence rate of infection in surgical patients with closed fractures treated prophylactically with Cefazolin versus Vancomycin in the peri-operative period.

The hypothesis of this study is that patients undergoing surgical treatment for closed fractures who are treated prophylactically with Vancomycin will have a lower incidence rate of infection than patients who are treated prophylactically with Cefazolin.

Conditions

Interventions

DRUG

Cefazolin

DRUG

Vancomycin

Sponsors & Collaborators

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Peter J Nowotarski, M.D. · UTCOM Chattanooga/Erlanger Health System

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2015-06-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02027532 on ClinicalTrials.gov